Home | Founder | What's New | In The News | Consulting | |||||||
H1N1 Consulting Paradigm Shift Intervention Monitoring |
Audio:Mar17
Apr21
Apr26
May19
twitter
Commentary Withheld CDC H274Y
H1N1Tamiflu
Resistance Sequences Earlier this season the CDC released four 2011 sequences from Delaware and four from Maryland and all eight sequences had H274Y. All eight sequences were collected in February or March and represent the eight most recent isolates from these two states. Phylogenetic analysis indicated H274Y was spreading via recombination and clonal expansion. One of the sequences, A/Maryland/04/2011, was from the Chihuahua sub-clade, while the other seven were from the S188T sub-clade. The first three sequences from Delaware had A189T, signaling clonal expansion. Moreover, the fourth Delaware sequence, A/Delaware/08/2011, was virtually identical to A/Maryland/06/2011, signaling additional clonal expansion. The H274Y was discovered through routine surveillance and was not linked to Tamiflu treatment raising concerns that the detection of H274Y in all eight of the most recent isolates from Delaware or Maryland signaled the start of significant spread of H274Y. These concerns were increased when Delaware announced ten additional cases with H274Y, as determined by the CDC, supporting significant spread. However, the recently released H1N1 sequences generated by the CDC did not include any of these ten samples or any additional samples from Delaware. Similarly, the recently released sequences did not include any samples from new patients in Maryland. The only Maryland sequence was an egg isolate of Maryland/04/2011 (which also had H274Y). thus, although all eight of the most recent isolates from Maryland and Delaware, the CDC failed to release any additional 2011 sequences from any new patients, even though Delaware had announced that then CDC had confirmed 10 additional cases. The withholding of these sequences by the CDC continues to increase pandemic concerns and evidence supporting the fixing of H274Y Tamiflu resistance in pandemic H1N1. Media Link Recombinomics
Presentations |
||||||||||
|
Webmaster:
webmaster@recombinomics.com
© 2011
Recombinomics. All
rights
reserved.